Finance

Beta
Lists
MEGA:BKK
Mega Lifesciences PCL
THB 35.50
-1.39%
(-0.50) 1D
Jun 2, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for MEGA...
Open
THB 35.75
High
THB 36.00
Low
THB 35.25
Mkt. cap
30.95B
Avg. vol.
911.31K
Volume
2.51M
52-wk high
THB 40.00
52-wk low
THB 24.60
Shares outstanding
871.87M
No. of employees
5K
Open
THB 35.75
High
THB 36.00
Low
THB 35.25
Mkt. cap
30.95B
Avg. vol.
911.31K
Volume
2.51M
52-wk high
THB 40.00
52-wk low
THB 24.60
Shares outstanding
871.87M
No. of employees
5K
News stories
From sources across the web
About Mega Lifesciences PCL
CEOVivek Dhawan
Employees5.4K
Founded1982
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.42B
3.89B
3.67B
3.44B
Cost of goods sold
1.67B
1.85B
1.71B
1.62B
Cost of revenue
1.67B
1.85B
1.71B
1.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14B
1.10B
1.17B
1.05B
Operating expense
1.14B
1.10B
1.17B
1.05B
Total operating expenses
2.81B
2.95B
2.88B
2.67B
Operating income
609.38M
935.02M
790.27M
762.00M
Other non operating income
-
-
-
-
EBT including unusual items
508.80M
623.30M
739.13M
779.90M
EBT excluding unusual items
508.80M
623.30M
739.13M
779.90M
Income tax expense
117.90M
129.09M
162.16M
175.30M
Effective tax rate
23.17%
20.71%
21.94%
22.48%
Other operating expenses
-
-
-
-
Net income
390.92M
494.19M
577.04M
604.60M
Net profit margin
11.43%
12.71%
15.71%
17.60%
Earnings per share
0.45
0.57
0.69
0.65
Interest and investment income
19.31M
20.17M
26.41M
-
Interest expense
-13.46M
-15.08M
-17.55M
-14.80M
Net interest expenses
5.85M
5.09M
8.87M
-14.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
662.14M
987.93M
838.04M
812.99M
Gain or loss from assets sale
-3.14M
-696.00K
-1.47M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more